| Stage | AMRC | % of rev | AGX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $515M | 100.00% | $384M | 100.00% | AMRC ×1.34 |
| Gross profit | $91M | 17.71% | $74M | 19.33% | AGX +1.6pp |
| Operating income | $44M | 8.49% | $57M | 14.79% | AGX +6.3pp |
| Pre-tax income | $20M | 3.89% | $67M | 17.42% | AGX +13.5pp |
| Net income | $20M | 3.86% | $53M | 13.88% | AGX +10.0pp |
| Stage | AMRC | AGX | Gap · A − B |
|---|---|---|---|
| Revenue | $515M100.00% | $384M100.00% | AMRC ×1.34 |
| Gross profit | 17.71%$91M | 19.33%$74M | AGX +1.6pp |
| Operating income | 8.49%$44M | 14.79%$57M | AGX +6.3pp |
| Pre-tax income | 3.89%$20M | 17.42%$67M | AGX +13.5pp |
| Net income |
| 3.86%$20M |
| 13.88%$53M |
| AGX +10.0pp |
No shared counterparties.